Skip to main content
Top
Published in: Rheumatology International 4/2006

01-02-2006 | Original Article

Body mass index and blood glucose: correlations with serum insulin, growth hormone, and insulin-like growth factor-1 levels in patients with diffuse idiopathic skeletal hyperostosis (DISH)

Authors: Charles W. Denko, Charles J. Malemud

Published in: Rheumatology International | Issue 4/2006

Login to get access

Abstract

Obesity is a frequent co-morbid condition associated with diffuse idiopathic skeletal hyperostosis (DISH). Serum growth hormone (GH), insulin-like growth factor (IGF-1) and insulin are significantly elevated in patients with DISH. In this study, we examined the relationship between body mass index (BMI) and basal serum GH, IGF-1, and insulin concentration in a group of 36 DISH patients. Basal serum insulin levels were significantly elevated (P<0.001) in DISH patients with a BMI>28 kg m−2, classified as obese, compared with DISH patients with BMI ranging from 23 to 28 kg m−2. In addition, BMI strongly positively correlated with serum insulin concentration in DISH patients (adjusted r2=0.348, P<0.001). However, BMI did not correlate with either basal serum GH (adjusted r2=−0.013) or IGF-1 levels (adjusted r2=−0.010) in DISH. We conclude that BMI does not seem to contribute to elevated serum GH and IGF-1 levels in symptomatic DISH.
Literature
1.
go back to reference Bideci A, Cinaz P, Hasanoglu A, Elberg S (1997) Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in obese children. J Pediatr Endocrinol Metab 10:295–299 Bideci A, Cinaz P, Hasanoglu A, Elberg S (1997) Serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in obese children. J Pediatr Endocrinol Metab 10:295–299
2.
go back to reference Argente J, Caballo N, Barrios V, Pozo J, Munoz MT, Chowen JA, Hernandez M (1997) Multiple endocrine abnormalities of growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction. J Clin Endocrinol Metab 82:2076–2083 Argente J, Caballo N, Barrios V, Pozo J, Munoz MT, Chowen JA, Hernandez M (1997) Multiple endocrine abnormalities of growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction. J Clin Endocrinol Metab 82:2076–2083
3.
go back to reference Saitoh H, Kamoda T, Nakahara S, Hirano T, Nakamura N (1998) Serum concentrations of insulin, insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-1 and −3 and growth hormone binding protein in obese children: fasting IGFBP-3 is suppressed in normoinsulinaemic obese children. Clin Endocrinol (Oxford) 48:487–492 Saitoh H, Kamoda T, Nakahara S, Hirano T, Nakamura N (1998) Serum concentrations of insulin, insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-1 and −3 and growth hormone binding protein in obese children: fasting IGFBP-3 is suppressed in normoinsulinaemic obese children. Clin Endocrinol (Oxford) 48:487–492
4.
go back to reference Park MJ, Kim HS, Kang JH, Kim DH, Chung CY (1999) Serum levels of insulin-like growth factor (IGF)-I, free IGF-I, IGF binding protein (IGFBP)-1, IGFBP-3 and insulin in obese children. J Pediatr Endocrinol Metab 12:139–144 Park MJ, Kim HS, Kang JH, Kim DH, Chung CY (1999) Serum levels of insulin-like growth factor (IGF)-I, free IGF-I, IGF binding protein (IGFBP)-1, IGFBP-3 and insulin in obese children. J Pediatr Endocrinol Metab 12:139–144
5.
go back to reference Murray RD, Adams JE, Shalet SM (2004) Adults with partial growth hormone deficiency have an adverse body composition. J Clin Endocrinol Metab 89:1586–1591 Murray RD, Adams JE, Shalet SM (2004) Adults with partial growth hormone deficiency have an adverse body composition. J Clin Endocrinol Metab 89:1586–1591
6.
go back to reference Russell-Jones Dl, Weissberger AJ (1996) The role of growth hormone in the regulation of body composition in the adult. Growth Regul 6:247–252 Russell-Jones Dl, Weissberger AJ (1996) The role of growth hormone in the regulation of body composition in the adult. Growth Regul 6:247–252
7.
go back to reference Shadid S, Jensen MD (2003) Effects of growth hormone administration in human obesity. Obes Res 11:170–175 Shadid S, Jensen MD (2003) Effects of growth hormone administration in human obesity. Obes Res 11:170–175
8.
go back to reference Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA (1984) Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Eng J Med 311:1403–1407 Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA (1984) Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Eng J Med 311:1403–1407
9.
go back to reference Cambien F (1987) Is insulin the key factor to explain the association between body mass, blood pressure and glucose? Diabetes Metab 13:365–368 Cambien F (1987) Is insulin the key factor to explain the association between body mass, blood pressure and glucose? Diabetes Metab 13:365–368
10.
go back to reference Moller LF, Jespersen J (1995) Elevated insulin levels in men: an 11-year follow-up study. J Cardiovasc Risk 2:339–343 Moller LF, Jespersen J (1995) Elevated insulin levels in men: an 11-year follow-up study. J Cardiovasc Risk 2:339–343
11.
go back to reference Frystyk J, Vestbo E, Skjaerbaek C, Morgensen CE, Orskov H (1995) Free insulin-like growth factors in obesity. Metabolism 44:37–44 Frystyk J, Vestbo E, Skjaerbaek C, Morgensen CE, Orskov H (1995) Free insulin-like growth factors in obesity. Metabolism 44:37–44
12.
go back to reference Strohl KP, Novak RD, Singer W, Cahan C, Boehm KD, Denko CW, Hoffstem VS (1994) Insulin levels, blood pressure and sleep apnea. Sleep 17:614–618PubMed Strohl KP, Novak RD, Singer W, Cahan C, Boehm KD, Denko CW, Hoffstem VS (1994) Insulin levels, blood pressure and sleep apnea. Sleep 17:614–618PubMed
13.
go back to reference Abbasi F, Carantoni M, McLaughlin T, Reaven GM (2000) Plasma insulin concentration is more tightly linked to plasma leptin concentration than is body mass index. Metabolism 49:544–547 Abbasi F, Carantoni M, McLaughlin T, Reaven GM (2000) Plasma insulin concentration is more tightly linked to plasma leptin concentration than is body mass index. Metabolism 49:544–547
14.
go back to reference Resnick D, Shaul SR, Robin JM (1975) Diffuse idiopathic skeletal hyperostosis (DISH): Forestier’s disease with extraspinal manifestations. Radiology 115:513–524 Resnick D, Shaul SR, Robin JM (1975) Diffuse idiopathic skeletal hyperostosis (DISH): Forestier’s disease with extraspinal manifestations. Radiology 115:513–524
15.
go back to reference Utsinger PD, Resnick D, Shapiro R (1976) Diffuse skeletal abnormalities in Forestier’s disease. Arch Int Med 136:763–768 Utsinger PD, Resnick D, Shapiro R (1976) Diffuse skeletal abnormalities in Forestier’s disease. Arch Int Med 136:763–768
16.
go back to reference Denko CW, Boja B, Moskowitz RW (1994) Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis–insulin, insulin-like growth factor-I, growth hormone. J Rheumatol 21:1725–1730PubMed Denko CW, Boja B, Moskowitz RW (1994) Growth promoting peptides in osteoarthritis and diffuse idiopathic skeletal hyperostosis–insulin, insulin-like growth factor-I, growth hormone. J Rheumatol 21:1725–1730PubMed
17.
go back to reference Littlejohn GO, Smythe HA (1984) Marked hyperinsulinemia after glucose challenge in patients with diffuse idiopathic skeletal hyperostosis. J Rheumatol 8:965–968 Littlejohn GO, Smythe HA (1984) Marked hyperinsulinemia after glucose challenge in patients with diffuse idiopathic skeletal hyperostosis. J Rheumatol 8:965–968
18.
go back to reference Denko CW, Boja B, Moskowitz RW (1996) Growth factors, insulin-like growth factor-1 and growth hormone, in synovial fluid and serum of patients with rheumatic disorders. Osteoarthr Cartilage 4:245–249 Denko CW, Boja B, Moskowitz RW (1996) Growth factors, insulin-like growth factor-1 and growth hormone, in synovial fluid and serum of patients with rheumatic disorders. Osteoarthr Cartilage 4:245–249
19.
go back to reference Denko CW, Malemud CJ (2002) Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH). Front Biosci 7:a37–a43PubMed Denko CW, Malemud CJ (2002) Growth hormone and insulin-like growth factor-I in symptomatic and asymptomatic patients with diffuse idiopathic skeletal hyperostosis (DISH). Front Biosci 7:a37–a43PubMed
20.
go back to reference Moskowitz RW, Holderbaum D (2001) Clinical and laboratory findings in osteoarthritis. In: McCarty DJ, Koopman WJ (eds) Arthritis and allied conditions (14th Edition). Lea & Febiger, Philadelphia Moskowitz RW, Holderbaum D (2001) Clinical and laboratory findings in osteoarthritis. In: McCarty DJ, Koopman WJ (eds) Arthritis and allied conditions (14th Edition). Lea & Febiger, Philadelphia
21.
go back to reference National Institutes of Health (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 6(Suppl 2):51S–209S National Institutes of Health (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults-the evidence report. Obes Res 6(Suppl 2):51S–209S
22.
go back to reference Bray GA (1998) In defense of a body mass index of 25 as the cutoff point for defining overweight. Obes Res 6:461–462 Bray GA (1998) In defense of a body mass index of 25 as the cutoff point for defining overweight. Obes Res 6:461–462
23.
go back to reference Denko CW, Malemud CJ (1999) Metabolic disturbances and synovial fluid responses in osteoarthritis. Front Biosci 4:d686–d693PubMed Denko CW, Malemud CJ (1999) Metabolic disturbances and synovial fluid responses in osteoarthritis. Front Biosci 4:d686–d693PubMed
24.
go back to reference Denko CW, Boja B, Malemud CJ (2003) Intra-erythrocyte deposition of growth hormone in rheumatic diseases. Rheumatol Int 23:11–14PubMed Denko CW, Boja B, Malemud CJ (2003) Intra-erythrocyte deposition of growth hormone in rheumatic diseases. Rheumatol Int 23:11–14PubMed
25.
go back to reference Vezyroglou G, Mitropoulos A, Antoniadis C (1996) A metabolic syndrome in diffuse idiopathic skeletal hyperostosis. A controlled study. J Rheumatol 23:672–676PubMed Vezyroglou G, Mitropoulos A, Antoniadis C (1996) A metabolic syndrome in diffuse idiopathic skeletal hyperostosis. A controlled study. J Rheumatol 23:672–676PubMed
26.
go back to reference Kiss C, Szilagyi M, Paksy A, Poor G (2002) Risk factors for diffuse idiopathic skeletal hyperostosis: a case-controlled study. Rheumatology (Oxford) 41:27–30 Kiss C, Szilagyi M, Paksy A, Poor G (2002) Risk factors for diffuse idiopathic skeletal hyperostosis: a case-controlled study. Rheumatology (Oxford) 41:27–30
27.
go back to reference Sarzi-Puttini P, Atzeni F (2004) New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis). Curr Opin Rheumatol 16:287–292 Sarzi-Puttini P, Atzeni F (2004) New developments in our understanding of DISH (diffuse idiopathic skeletal hyperostosis). Curr Opin Rheumatol 16:287–292
28.
go back to reference Woo J, Ho SC, Yu AL, Sham A (2002) Is waist circumference a useful measure of predicting health outcomes in the elderly? Int J Obes Related Metab Disord 26:1349–1355 Woo J, Ho SC, Yu AL, Sham A (2002) Is waist circumference a useful measure of predicting health outcomes in the elderly? Int J Obes Related Metab Disord 26:1349–1355
29.
go back to reference Chan DC, Watts GF, Barrett PH, Burke V (2003) Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men. QJM 96:441–447 Chan DC, Watts GF, Barrett PH, Burke V (2003) Waist circumference, waist-to-hip ratio and body mass index as predictors of adipose tissue compartments in men. QJM 96:441–447
30.
go back to reference Deurenberg P, Yap M (1999) The assessment of obesity: methods for measuring body fat and global prevalence of obesity. Baillieres Best Pract Res Clin Endocrinol Metab 13:1–11 Deurenberg P, Yap M (1999) The assessment of obesity: methods for measuring body fat and global prevalence of obesity. Baillieres Best Pract Res Clin Endocrinol Metab 13:1–11
31.
go back to reference Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R (2002) Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 75:683–688 Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R (2002) Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr 75:683–688
32.
go back to reference Janssen I, Katzmarzyk PT, Ross R (2004) Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79:379–384 Janssen I, Katzmarzyk PT, Ross R (2004) Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr 79:379–384
33.
go back to reference Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC (2001) Diet, lifestyle and the risk of diabetes mellitus in women. N Eng J Med 345:790–797 Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG, Willett WC (2001) Diet, lifestyle and the risk of diabetes mellitus in women. N Eng J Med 345:790–797
Metadata
Title
Body mass index and blood glucose: correlations with serum insulin, growth hormone, and insulin-like growth factor-1 levels in patients with diffuse idiopathic skeletal hyperostosis (DISH)
Authors
Charles W. Denko
Charles J. Malemud
Publication date
01-02-2006
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2006
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-005-0588-8

Other articles of this Issue 4/2006

Rheumatology International 4/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.